Boule Diagnostics Seeks Shareholder Approval for SEK 93.2 Million Rights Issue

Bitget2026/11/04 07:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Boule Diagnostics’ board seeks shareholder approval for a fully secured SEK 93.2 million rights issue at an extraordinary meeting planned for December 7, 2026.
Existing shareholders may subscribe for three new shares per existing share at SEK 0.80 each.
The board also proposes an over-allotment option of up to SEK 62.7 million for external investors at the same subscription price.
Maximum dilution would reach 83.4% for nonparticipating shareholders if the rights issue is fully subscribed and the over-allotment option fully exercised.
Proceeds will finance restructuring as the company exits instruments to focus on consumables, service and OEM operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boule Diagnostics AB published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Boule Diagnostics Seeks Shareholder Approval for SEK 93.2 Million Rights Issue

You may also like

Crypto prices